A new deal signed with AstraZeneca confirms the acquisition of 60 million vaccines next year for Thailand to use as booster shot third vaccines. The Ministry of Public Health signed the take care of the Covid-19 vaccine producer to amass the booster shots over the course of 3 quarters of 2022.
The signing was accompanied by a ceremony attended by Minister of Public Health Anutin Charnvirakul and Department of Disease Director-General Control Dr Opas Karnkawinpong in addition to AstraZeneca Thailand representatives.
The plan requires a rollout of a first-quarter supply of 15 million vaccines, followed by a second supply of 30 million vaccines in the second quarter. The remaining 15 million vaccines of the deal could be delivered in the third quarter of 2022.
The contract deal between Thailand and AstraZeneca will see Thailand paying about 18 billion baht for the 60 million vaccines. That’s about 300 baht per vaccine.
A clause in the purchase contract with AstraZeneca offers the option of Thailand switching the deliveries to any newer model of the AstraZeneca Covid-19 vaccine that the producers would possibly develop between now and the delivery date. The company is presently engaged on a second-generation vaccine already.
There was no point out in the report by MCOT of regionally produced AstraZeneca vaccines produced by Siam Bioscience, a company wholly owned by a subsidiary of Crown Property Bureau. The native production was imagined to ship 10 million vaccines a month to be used in Thailand, whereas exporting extra to the Southeast Asia area, a plan that has introduced controversy and debate.
Prize has been receiving AstraZeneca vaccines lately by way of donations by Japan and from Singapore..